placeholder image
Vaccine Safety Datalink (VSD) Team All authors
About
Publications While At 开云体育
selected publications
Journal Article
  • Attitudes toward COVID-19 vaccines among pregnant and recently pregnant individuals. 
    JAMA network open. 2024
  • COVID-19 vaccination in the first trimester and major structural birth defects among live births. 
    JAMA pediatrics. 2024
  • Coronavirus disease 2019 (COVID-19) vaccination and stillbirth in the Vaccine Safety Datalink. 
    Obstetrics and Gynecology. 2024
  • Impact of the COVID-19 pandemic on health care utilization in the Vaccine Safety Datalink: retrospective cohort study. 
    JMIR public health and surveillance. 2024
  • Increased identification of vaccines for vaccine safety surveillance through linkage with the Minnesota Immunization Information Connection as of December 31, 2023. 
    Public Health Reports. 2024
  • Lack of evidence for vaccine-associated enhanced disease from COVID-19 vaccines among adults in the Vaccine Safety Datalink. 
    Pharmacoepidemiology and Drug Safety. 2024
  • Obstetric complications and birth outcomes after antenatal coronavirus disease 2019 (COVID-19) vaccination. 
    Obstetrics and Gynecology. 2024
  • Tinnitus after COVID-19 vaccination: findings from the vaccine adverse event reporting system and the vaccine safety datalink. 
    American Journal of Otolaryngology. 2024
  • A broad assessment of COVID-19 vaccine safety using tree-based data-mining in the vaccine safety datalink. 
    Vaccine. 2023
  • A safety study evaluating non-COVID-19 mortality risk following COVID-19 vaccination. 
    Vaccine. 2023
  • Active postlicensure safety surveillance for recombinant zoster vaccine using electronic health record data. 
    American Journal of Epidemiology. 2023
  • Association between aluminum exposure from vaccines before age 24 months and persistent asthma at age 24 to 59 months. 
    Academic Pediatrics. 2023
  • COVID-19 booster vaccination in early pregnancy and surveillance for spontaneous abortion. 
    JAMA network open. 2023
  • COVID-19 vaccine safety surveillance in early pregnancy in the United States: design factors affecting the association between vaccine and spontaneous abortion. 
    American Journal of Epidemiology. 2023
  • Influenza vaccination coverage among persons ages six months and older in the Vaccine Safety Datalink in the 2017-18 through 2022-23 influenza seasons. 
    Vaccine. 2023
  • Safety of measles, mumps, and rubella vaccine in adolescents and adults in the Vaccine Safety Datalink. 
    Vaccine. 2023
  • Safety of simultaneous vaccination with COVID-19 vaccines in the Vaccine Safety Datalink. 
    Vaccine. 2023
  • Safety signal identification for COVID-19 bivalent booster vaccination using tree-based scan statistics in the Vaccine Safety Datalink. 
    Vaccine. 2023
  • Tree-based data mining for safety assessment of first COVID-19 booster doses in the Vaccine Safety Datalink. 
    Vaccine. 2023
  • Association of the COVID-19 pandemic with routine childhood vaccination rates and proportion up to date with vaccinations across 8 US health systems in the Vaccine Safety Datalink. 
    JAMA pediatrics. 2022
  • Changes in incidence rates of outcomes of interest in vaccine safety studies during the COVID-19 pandemic. 
    Vaccine. 2022
  • Effectiveness of BNT162b2 and mRNA-1273 second doses and boosters for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and SARS-CoV-2-related hospitalizations: a statewide report from the Minnesota Electronic Health Record Consortium. 
    Clinical Infectious Diseases. 2022
  • Evaluation of acute adverse events after Covid-19 vaccination during pregnancy. 
    New England Journal of Medicine. 2022
  • Health care utilization in the 6 months following SARS-CoV-2 infection. 
    JAMA network open. 2022
  • Incidence of Guillain-Barr茅 syndrome after COVID-19 vaccination in the Vaccine Safety Datalink. 
    JAMA network open. 2022
  • Kawasaki disease following the 13-valent pneumococcal conjugate vaccine and rotavirus vaccines. 
    Pediatrics. 2022
  • Monitoring vaccine safety using the Vaccine Safety Datalink: assessing capacity to integrate data from Immunization Information systems. 
    Vaccine. 2022
  • Receipt of COVID-19 vaccine during pregnancy and preterm or small-for-gestational-age at birth - eight integrated health care organizations, United States, December 15, 2020-July 22, 2021. 
    MMWR: Morbidity and Mortality Weekly Report. 2022
  • Risk of myocarditis and pericarditis following BNT162b2 and mRNA-1273 COVID-19 vaccination. 
    Vaccine. 2022
  • Safety of COVID-19 vaccination in United States children ages 5 to 11 years. 
    Pediatrics. 2022
  • Travelers and travel vaccines at six health care systems in the Vaccine Safety Datalink. 
    Vaccine. 2022
  • COVID-19 vaccination coverage among insured persons aged 鈮�16 years, by race/ethnicity and other selected characteristics - eight integrated health care organizations, United States, December 14, 2020-May 15, 2021. 
    MMWR: Morbidity and Mortality Weekly Report. 2021
  • COVID-19 vaccination coverage among pregnant women during pregnancy - eight integrated health care organizations, United States, December 14, 2020-May 8, 2021. 
    MMWR: Morbidity and Mortality Weekly Report. 2021
  • Incidence of pediatric inflammatory bowel disease within the Vaccine Safety Datalink network and evaluation of association with rotavirus vaccination. 
    Vaccine. 2021
  • Surveillance for adverse events after COVID-19 mRNA vaccination. 
    JAMA. 2021
  • Vaccine Safety Datalink infrastructure enhancements for evaluating the safety of maternal vaccination. 
    Therapeutic advances in drug safety. 2021
  • Evaluating the association of stillbirths after maternal vaccination in the Vaccine Safety Datalink. 
    Obstetrics and Gynecology. 2020
  • SARS-CoV-2 infection among hospitalized pregnant women: reasons for admission and pregnancy characteristics - eight U.S. health care centers, March 1-May 30, 2020. 
    MMWR: Morbidity and Mortality Weekly Report. 2020
  • Uptake and safety of hepatitis A vaccination during pregnancy: a Vaccine Safety Datalink study. 
    Vaccine. 2019
  • Safety of repeated doses of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccine in adults and adolescents. 
    Pharmacoepidemiology and Drug Safety. 2018
  • Uptake and safety of Hepatitis B vaccination during pregnancy: a Vaccine Safety Datalink study. 
    Vaccine. 2018
  • Identifying birth defects in automated data sources in the Vaccine Safety Datalink. 
    Pharmacoepidemiology and Drug Safety. 2017
  • Immunization: Vaccine Safety Datalink. 
    Minn Physician. 2017
  • Live attenuated influenza vaccine use and safety in children and adults with asthma. 
    Annals of Allergy, Asthma, and Immunology. 2017
  • Influenza vaccination during pregnancy: influenza seasons 2002-2012, Vaccine Safety Datalink. 
    American Journal of Preventive Medicine. 2016
  • Maternal Tdap vaccination: coverage and acute safety outcomes in the vaccine safety datalink, 2007-2013. 
    Vaccine. 2016
  • Safety of measles-containing vaccines in 1-year-old children. 
    Pediatrics. 2015
  • Safety of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis and influenza vaccinations in pregnancy. 
    Obstetrics and Gynecology. 2015
  • Monovalent H1N1 influenza vaccine safety in pregnant women, risks for acute adverse events. 
    Vaccine. 2014
  • Receipt of pertussis vaccine during pregnancy across 7 Vaccine Safety Datalink Sites. 
    Preventive Medicine. 2014
  • Safety of diphtheria, tetanus, acellular pertussis and inactivated poliovirus (DTaP-IPV) vaccine. 
    Vaccine. 2014
  • Timely versus delayed early childhood vaccination and seizures. 
    Pediatrics. 2014
  • Guillain-Barre syndrome, influenza vaccination, and antecedent respiratory and gastrointestinal infections: a case-centered analysis in the Vaccine Safety Datalink, 2009-2011. 
    PloS One. 2013
  • Identifying pregnancy episodes, outcomes, and mother-infant pairs in the Vaccine Safety Datalink. 
    Vaccine. 2013
  • Maternal safety of trivalent inactivated influenza vaccine in pregnant women. 
    Obstetrics and Gynecology. 2013
  • Risk of adverse events following oseltamivir treatment in influenza outpatients, Vaccine Safety Datalink Project, 2007-2010. 
    Pharmacoepidemiology and Drug Safety. 2013
  • Safety of a tetanus-diphtheria-acellular pertussis vaccine when used off-label in an elderly population. 
    Clinical Infectious Diseases. 2013
  • Safety of the yellow fever vaccine: a retrospective study. 
    Journal of Travel Medicine. 2013
  • Secular trends in diagnostic code density in electronic healthcare data from health care systems in the Vaccine Safety Datalink Project. 
    Vaccine. 2013
  • Trivalent inactivated influenza vaccine and spontaneous abortion. 
    Obstetrics and Gynecology. 2013
  • Vaccination site and risk of local reactions in children 1 through 6 years of age. 
    Pediatrics. 2013
  • Measles-containing vaccines and febrile seizures in children age 4 to 6 years. 
    Pediatrics. 2012
  • Patterns in influenza antiviral medication use before and during the 2009 H1N1 pandemic, Vaccine Safety Datalink Project, 2000-2010. 
    Influenza and other respiratory viruses. 2012
  • Safety of zoster vaccine in adults from a large managed-care cohort: a Vaccine Safety Datalink study. 
    Journal of Internal Medicine. 2012
  • Monitoring vaccine safety using the Vaccine Safety Datalink: utilizing immunization registries for pandemic influenza. 
    Vaccine. 2011
  • Safety of trivalent inactivated influenza vaccine in children aged 24 to 59 months in the vaccine safety datalink. 
    Archives of Pediatrics and Adolescent Medicine. 2011
  • Near real-time surveillance for influenza vaccine safety: proof-of-concept in the Vaccine Safety Datalink Project. 
    American Journal of Epidemiology. 2010
  • Accuracy of data on influenza vaccination status at four Vaccine Safety Datalink sites. 
    American Journal of Preventive Medicine. 2009
  • An assessment of the safety of adolescent and adult tetanus-diphtheria-acellular pertussis (Tdap) vaccine, using active surveillance for adverse events in the Vaccine Safety Datalink. 
    Vaccine. 2009
  • Frequency of medically attended adverse events following tetanus and diphtheria toxoid vaccine in adolescents and young adults: a Vaccine Safety Datalink study. 
    BMC Infectious Diseases. 2009
  • Risk of medically attended local reactions following diphtheria toxoid containing vaccines in adolescents and young adults: a Vaccine Safety Datalink study. 
    Vaccine. 2009
    • Conference Poster
  • Acute adverse events following trivalent inactivated influenza vaccine (TIV) in pregnancy [poster]
    2012
  • Safety of seasonal influenza vaccine (TIV) in pregnant women [poster]
    2011
  • Safety of the yellow fever vaccine: a retrospective study [poster]
    2011
  • Vaccine Safety Datalink (VSD): the dynamic data files (DDF) [poster]
    2008
    • Review
  • The Vaccine Safety Datalink: successes and challenges monitoring vaccine safety [review]. 
    Vaccine. 2014
  • Assessing the safety of influenza immunization during pregnancy: the Vaccine Safety Datalink [review]. 
    American Journal of Obstetrics and Gynecology. 2012
    • Abstract
  • A descriptive study of vaccinations occurring during pregnancy, 2002-2006 [abstract]. 
    Clinical Medicine & Research. 2012
  • Identifying pregnancy episodes in the Vaccine Safety Datalink [abstract]. 
    Clinical Medicine & Research. 2012
    • Book
  • White paper on the safety of the childhood immunization schedule
    2016
    • presentations
    Contact
    full name
  • Vaccine Safety Datalink (VSD) Team
    • Quick Info
    Publications
    Publications in the past 10 years based solely on publications while at 开云体育. Publications in prior years appear in grey.
    Collaboration